← All products
A12/00432/22

Skin-lightening cream

Fairness · Cream

CosmeticsChemical
Notifying country
Sweden
Open the alert on the European Commission website ↗

What is the danger

The product contains hydroquinone (declared value 2% by weight) which can cause skin irritation and dermatitis. It also contains mometasone (declared value 0,10% by weight). Mometasone is a corticosteroid that should be made available only under medical prescription: exposure to it could cause skin irritation and may lead to endocrine problems.

Requirements breached

The product does not comply with the Cosmetic Products Regulation.

Measures taken

  1. Stop of sales Voluntary measuresTaken by: Retailer

Product

Description
Skin-lightening cream
Packaging
Cardboard box
Brand
Fairness
Batch
FR2002

Original source

Data comes from the official Safety Gate system of the European Commission.

Alert number
A12/00432/22 ↗
Weekly report
Report-2022-11
Published
16 March 2022
Modified
30 June 2022

© European Union, Safety Gate · https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10005758

Your reaction
Found a mistake? Let us know

Only the site administrator will see your message.